Franck S, van der Lely A, Neggers S
Eur Endocrinol. 2018; 9(1):66-70.
PMID: 30349613
PMC: 6193516.
DOI: 10.17925/EE.2013.09.01.66.
Krebs M, Brehm A, Krssak M, Anderwald C, Bernroider E, Nowotny P
Diabetologia. 2003; 46(7):917-25.
PMID: 12819901
DOI: 10.1007/s00125-003-1129-1.
Ghigo E, Aimaretti G, Arvat E, Camanni F
Endocrine. 2001; 15(1):29-38.
PMID: 11572322
DOI: 10.1385/ENDO:15:1:029.
Sasaki Y, Takahashi H
J Physiol. 1983; 334:155-67.
PMID: 6345757
PMC: 1197306.
DOI: 10.1113/jphysiol.1983.sp014486.
Riggs L, Rabinowitz D, Merimee T
Postgrad Med J. 1967; 43(501):458-61.
PMID: 6041638
PMC: 2466333.
DOI: 10.1136/pgmj.43.501.458.
The role of aminogenic glucagon secretion in blood glucose homeostasis.
Unger R, OHNEDA A, EISENTRAUT A
J Clin Invest. 1969; 48(5):810-22.
PMID: 5780193
PMC: 322289.
DOI: 10.1172/JCI106039.
Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids.
OHNEDA A, Parada E, EISENTRAUT A, Unger R
J Clin Invest. 1968; 47(10):2305-22.
PMID: 5676526
PMC: 297395.
DOI: 10.1172/JCI105916.
Factors controlling blood glucose--with remarks on the effect of insulin on muscle.
Lundbaek K
Proc R Soc Med. 1968; 61(8):807-11.
PMID: 5673411
PMC: 1902466.
Adrenergic receptor control mechanism for growth hormone secretion.
BLACKARD W, Heidingsfelder S
J Clin Invest. 1968; 47(6):1407-14.
PMID: 5653218
PMC: 297296.
DOI: 10.1172/JCI105832.
Endocrinological studies in ataxiatelangiectasia and other immunological deficiency diseases.
Ammann A, Duquesnoy R, GOOD R
Clin Exp Immunol. 1970; 6(4):587-95.
PMID: 5477923
PMC: 1712790.
[Effect of prolonged fasting and of low-calorie diet on plasmatic levels of somatotropin and of insulin in obese subjects].
Iacono G, Del Giudice N, Ghionni A, Colucci M, Palomba D
Acta Diabetol Lat. 1971; 8(3):500-21.
PMID: 5116956
DOI: 10.1007/BF01550884.
Fetal insulin and growth hormone metabolism in the subhuman primate.
Mintz D, Chez R, HORGER 3rd E
J Clin Invest. 1969; 48(1):176-86.
PMID: 4974624
PMC: 322203.
DOI: 10.1172/JCI105966.
[Behavior of somatotropic hormone and plasmatic NEFA during function tests in essential obesity].
Iacono G, Ghionni A, Palomba D, Del Giudice N, Colucci M
Acta Diabetol Lat. 1971; 8(1):84-98.
PMID: 4937338
DOI: 10.1007/BF01550859.
Changing concepts on the control of growth hormone secretion in man.
VANDERLAAN W
Calif Med. 1971; 115(2):38-46.
PMID: 4935302
PMC: 1518007.
Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
Imura H, Kato Y, Ikeda M, Morimoto M, Yawata M
J Clin Invest. 1971; 50(5):1069-79.
PMID: 4928263
PMC: 292029.
DOI: 10.1172/JCI106578.
[Human growth hormone].
Illig R, ZACHMANN M, PRADER A
Klin Wochenschr. 1969; 47(3):118-23.
PMID: 4905737
DOI: 10.1007/BF01746044.
[Growth hormone release in unstable diabetes: tests with saline, arginine, glucagon, and epinephrine (author's transl)].
Cremer G, MOLNAR G, Taylor W, ROSEVEAR J, ACKERMAN E
Acta Diabetol Lat. 1973; 10(6):1216-35.
PMID: 4793673
DOI: 10.1007/BF02590712.
[Regulation of somatotropin secretion: attempted unitary interpretation].
Vigneri R, Squatrito S, Motta L, Pezzino V, POLOSA P
Acta Diabetol Lat. 1973; 10(1):91-106.
PMID: 4713541
DOI: 10.1007/BF02590653.
Response of glucose, insulin, free fatty acid, and human growth hormone to norepinephrine and hemorrhage in normal man.
Hanson E, Brennan M, OConnell R, MOORE F
Ann Surg. 1973; 177(4):453-7.
PMID: 4691864
PMC: 1355655.
DOI: 10.1097/00000658-197304000-00012.
Growth hormone. Control of release and characteristics in plasma.
Beck J, Bala M, Ferguson K, Kudo C, Rubinstein D
Trans Am Clin Climatol Assoc. 1972; 83:18-44.
PMID: 4625131
PMC: 2441261.
